Hongsen Investment
Mr. Hui is a successful entrepreneur and investor and is a Managing Director of Pandect Bioventures. He also serves as Chairman and CEO of ShangPharma Holdings, Vice Chairman of Quantum Hi-Tech Biological, Chairman of Shanghai ChemPartner, and Chairman of ShangPharma Innovation.
Mr. Hui holds Bachelor’s and Master’s degrees in Chemistry from Oregon State University and Tulane University, respectively, and an MBA from the Stern School of Business of New York University.
This person is not in any offices
Hongsen Investment
Hongsen Investment is a strong and experienced management team, with over 100 years of collective experience in investing, biotech & healthcare, business operations and capital market experience. Hongsen Investment focuses on growing biotech companies with a strong team, proven technology, and sound business model, along with companies that have clear arbitrage and exit plans.